Coronary Heart Disease: Clinical Trials

28 trials for Coronary Heart Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

28 unknown. 28 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 428Unknown 28

Follow Coronary Heart Disease: new trials by email Literature Review of Coronary Heart Disease trials Research Report on Coronary Heart Disease

Trials (filtered) newest first · largest first

All 28 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ticagrelor Single Antiplatelet Therapy in Patients With High Risk of Bleeding After DCB for Coronary Small Vessel Disease
Ticagrelor, Clopidogrel, Aspirin - Coronary Heart Disease
Phase 4UnknownFu Wai Hospital, Beijing, China2922023-11-152023-10-18
HuoXin Pills Intervention on Patients With Coronary Heart Disease After Drug-Coated Balloon Implantation
Yuekang Huoxin Pills (concentrated pills), Yuekang Huoxin Pills (concentrated pills)simulant - Coronary Heart Disease, Medicine, Chinese Traditional
Phase 4UnknownChina National Center for Cardiovascular Diseases4402022-08-052022-08-17
Effect of Nicorandil on Cardiac Sympathetic Nerve for the Patients of Acute ST Segment Elevation Myocardial Infarction
nicorandil, Placebo(normal saline) - Coronary Heart Disease
Phase 4UnknownXuzhou Central Hospital802021-04-012021-04-01
Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris
Wen Xin granule, Clopidogrel Hydrogen Sulfate 75 MG Oral Tablet, Atorvastatin Calcium - Coronary Heart Disease, Unstable Angina
Phase 4UnknownGuang'anmen Hospital of China Academy of Chinese Medical Sciences5022021-03-012021-01-25
Evaluate the Efficacy and Safety of MUSK Pill on Coronary Microvascular Dysfunction
MUSK pill - Angina Pectoris, Coronary Heart Disease
Phase 4UnknownShanghai Hutchison Pharmaceuticals Limited2642021-01-282021-08-02
Efficacy and Safety of Yangxin Shengmai Granules for the Treatment of Stable Angina Pectoris
Yangxin Shengmai, Yangxin Shengmai placebo, nitroglycerin tablets - Coronary Heart Disease, Stable Angina
Phase 4UnknownGuang'anmen Hospital of China Academy of Chinese Medical Sciences802020-12-012020-11-13
Efficacy and Safety of Xueshuanxinmaining Tablet for the Treatment of Stable Angina Pectoris
Xueshuanxinmaining tablet, Xueshuanxinmaining placebo, Nitroglycerin tablets - Coronary Heart Disease, Stable Angina
Phase 4UnknownGuang'anmen Hospital of China Academy of Chinese Medical Sciences1202020-12-012020-11-13
Comparison Between Propofol and Inhalational Anaesthetic Agents on Cardiovascular Outcomes Following Cardiac Surgery
Isoflurane, Sevoflurane or Desflurane, Propofol - Coronary Heart Disease, Cardiovascular Diseases
Phase 4UnknownKing's College Hospital NHS Trust502019-11-202021-02-24
Cardiac Metabolic Modulator Treatment for Improvement of Diastolic Function in Patients With Coronary Heart Disease
Trimetazidine - Coronary Heart Disease, Diastolic Dysfunction
Phase 4UnknownChina National Center for Cardiovascular Diseases2262019-03-252019-03-25
Different Dosage of Domestic and Imported Clopidogrel on the Platelet Inhibition Ratio in Patients Undergoing PCI
Clopidogrel - Coronary Heart Disease
Phase 4UnknownXijing Hospital1202017-01-012016-12-30
The Effect of Tongguan Capsule for MicroRNA Profiles in Coronary Heart Disease Patients
Tongguan capsule, placebo capsule - Coronary Heart Disease, Acute Myocardial Infarction
Phase 4UnknownGuangdong Provincial Hospital of Traditional Chinese Medicine1002016-07-012016-08-02
Studies of Application of Combined General Anesthesia and Bilateral TPVB in OPCABG
bilateral thoracic paravertebral block, Transesophageal Echocardiography(TEE), Lung protection measure during the surgery(Dräger Primus) - Coronary Heart Disease
Phase 4UnknownXiangya Hospital of Central South University602016-04-012016-04-05
Effect of Rosuvastatin Therapy on HDL2 Level
Rosuvastatin 10mg/d group, Rosuvastatin 20mg/d group - Hyperlipemia, Coronary Heart Disease
Phase 4UnknownDaping Hospital and the Research Institute of Surgery of the Third Military Medical University3002015-11-012015-11-03
Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction
Nicorandil, normal saline - Coronary Heart Disease
Phase 4UnknownXuzhou Central Hospital1002015-04-012015-05-06
Relation Among Shear Stress Distribution, Stent Design, and Subsequent Vessel Healing After Drug-eluting Stent Implantation (SHEAR DES)
Promus element, Xience prime, and Nobori - Coronary Heart Disease
Phase 4UnknownKobe University302013-02-012013-09-13
Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function
danshen dripping pill - Coronary Heart Disease, Essential Hypertension
Phase 4UnknownWest China Hospital2002013-01-012013-04-08
Fluvastatin AmelIorates aTHerosclerosis Study
Fluvastatin extended release tablet - Coronary Heart Disease, Atherosclerosis
Phase 4UnknownBeijing Anzhen Hospital1402012-07-012012-09-07
Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function Testing
Ticagrelor, Prasugrel - Coronary Heart Disease
Phase 4UnknownDeutsches Herzzentrum Muenchen702011-09-012013-11-01
Ischemia In Hemodialysed Patients: Ivabradine Versus Carvedilol
Ivabradine, Carvedilol - Coronary Heart Disease, Angina
Phase 4UnknownUniversity of Campania Luigi Vanvitelli2202011-01-012012-06-28
Test of Long-Term Safety and Efficacy of Sirolimus-Permanent-Polymer Eluting Stent (Cypher)- and Sirolimus-Polymer-free Eluting Stents (PPS/PFS) Assessed by Optical Coherence Tomography
Sirolimus-Permanent-Polymer Eluting Stent, Sirolimus-Polymer-free Eluting Stent - Coronary Heart Disease
Phase 4UnknownDeutsches Herzzentrum Muenchen202010-12-012012-05-08

Showing 20 of 28. Sign in to see all of them.

Narrower conditions

Coronary Disease (28)  ·  Angina Pectoris (2)  ·  Angina, Stable (2)  ·  Atherosclerosis (2)  ·  Coronary Artery Disease (2)  ·  ST Elevation Myocardial Infarction (2)  ·  Acute Coronary Syndrome (1)  ·  Angina, Unstable (1)  ·  Calcinosis (1)  ·  Cardiovascular Diseases (1)  ·  Diabetes Mellitus (1)  ·  Essential Hypertension (1)  ·  Hypercholesterolemia (1)  ·  Hyperlipidemias (1)  ·  Inflammation (1)

Broader conditions

Heart Diseases (28)  ·  Myocardial Ischemia (28)  ·  Vascular Diseases (28)  ·  Cardiovascular Diseases (27)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Chest Pain (5)  ·  Neurologic Manifestations (5)  ·  Pain (5)  ·  Signs and Symptoms (5)  ·  Angina Pectoris (3)  ·  Arterial Occlusive Diseases (3)  ·  Arteriosclerosis (3)  ·  Metabolic Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Pathologic Processes (3)

Interventions

Clopidogrel (3)  ·  Nitroglycerin (3)  ·  Atorvastatin (2)  ·  Nicorandil (2)  ·  Saline Solution (2)  ·  Ticagrelor (2)  ·  Trimetazidine (2)  ·  Aspirin (1)  ·  Carvedilol (1)  ·  Control Groups (1)  ·  Desflurane (1)  ·  Fluvastatin (1)  ·  Isoflurane (1)  ·  Ivabradine (1)  ·  Metoprolol (1)

Sponsors

Deutsches Herzzentrum Muenchen (4)  ·  Guang'anmen Hospital of China Academy of Chinese Medical Sciences (3)  ·  China National Center for Cardiovascular Diseases (2)  ·  Xuzhou Central Hospital (2)  ·  Abant Izzet Baysal University (1)  ·  Beijing Anzhen Hospital (1)  ·  Daping Hospital and the Research Institute of Surgery of the Third Military Medical University (1)  ·  Fu Wai Hospital, Beijing, China (1)  ·  Guangdong Provincial Hospital of Traditional Chinese Medicine (1)  ·  King's College Hospital NHS Trust (1)  ·  Kobe University (1)  ·  Masaryk University (1)  ·  National Taiwan University Hospital (1)  ·  Seoul National University Hospital (1)  ·  Shanghai Hutchison Pharmaceuticals Limited (1)

Countries

China (10)  ·  Germany (4)  ·  South Korea (2)  ·  Canada (1)  ·  Czechia (1)  ·  Hungary (1)  ·  Italy (1)  ·  Japan (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Jun Li, MD (2)  ·  Klaus Tiroch, MD (2)  ·  Daniel Aradi, MD (1)  ·  Dr Gudrun Kunst (1)  ·  Gennaro Cice, MD (1)  ·  HaiMing Shi, doctor (1)  ·  Haiyan Qian, MD, PhD (1)  ·  Hiromasa Otake, MD, PhD (1)  ·  Huizheng Zhu, PhD (1)  ·  Hyo-Soo Kim, MD, PhD (1)  ·  Hyuk-Jae Chang, MD, PhD (1)  ·  Julinda Mehilli, MD (1)  ·  Jun Li, M.D. (1)  ·  Katharina Mayer, MD (1)

Results publications

PMID 10527232, PMID 11426357, PMID 12607706, PMID 15791442, PMID 17898099, PMID 18603748, PMID 18955731, PMID 22463698, PMID 22584085, PMID 22719784, PMID 23428644, PMID 23754711, PMID 24050860, PMID 24465490, PMID 24528685, PMID 24579987, PMID 24595147, PMID 24739590, PMID 24814486, PMID 25532378, PMID 26972437, PMID 28497986, PMID 28886621, PMID 28966311, PMID 29107310, PMID 29495982, PMID 29891250, PMID 30918578, PMID 31118574, PMID 31147987, PMID 31829173, PMID 31855330, PMID 31860998, PMID 31883335, PMID 34774099, PMID 38724266

NIH funding

2019 (1)